Study guide

2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP

IJCAHPO Certified Retina Technician CRT

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview: Current CRT Requirements & Blueprint

Exam Overview: Current Requirements, Scope & Study Plan

2 Chapter 1: History Taking, Triage & Clinical Documentation

1.1 Comprehensive Ophthalmic & Medical History for Retina Patients 1.2 Telephone Triage, Urgent Symptoms & Emergency Scheduling 1.3 Scribing, Electronic Health Records & Retinal Billing Codes

3 Chapter 2: Visual Assessment & Low Vision Rehabilitation

2.1 Standardized Visual Acuity Testing & Optotypes 2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP 2.3 Low Vision Definitions, Optical Devices & Patient Counseling

4 Chapter 3: Pupil Assessment & Visual Field Testing

3.1 Pupillary Examination & Relative Afferent Pupillary Defect 3.2 Confrontation Fields & Automated Perimetry in Retina 3.3 Amsler Grid Testing & Metamorphopsia Monitoring

5 Chapter 4: Tonometry & Ocular Motility

4.1 Goldmann Applanation & Handheld Tonometry Techniques 4.2 Tonometer Disinfection, Calibration & Post-Procedure IOP Monitoring 4.3 Ocular Motility Assessment, Strabismus & Alignment Testing

6 Chapter 5: Diagnostic Ophthalmic Ultrasound

5.1 Ophthalmic B-Scan Echography for Posterior Segment Pathology 5.2 Standardized A-Scan Echography & Optical Biometry

7 Chapter 6: Slit Lamp, Electrophysiology & Supplemental Testing

6.1 Slit Lamp Biomicroscopy, Illumination & Fundus Lenses 6.2 Color Vision Assessment & Hertel Exophthalmometry 6.3 Ophthalmic Electrophysiology: ERG, VEP, and EOG

8 Chapter 7: Ophthalmic Microbiology & Infection Control

7.1 Ocular Pathogens & Routes of Disease Transmission 7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection

9 Chapter 8: General Retinal Pharmacology & Therapeutics

8.1 Ocular Drug Delivery Methods & Routes of Administration 8.2 Mydriatics, Cycloplegics & Diagnostic Ophthalmic Dyes 8.3 Anesthetics, Glaucoma Agents & Prescription Verification

10 Chapter 9: Anti-VEGF Therapies, Steroids & Retinal Toxicity

9.1 Anti-VEGF Agents & Neovascular Retinal Diseases 9.2 Corticosteroids, Sustained-Release Implants & AREDS Supplements 9.3 Systemic Medication Retinal Toxicity & Plaquenil Screening

11 Chapter 10: Surgical Assisting & Intravitreal Procedures

10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks 10.2 Retinal Laser Therapy Modalities & Laser Safety Protocols 10.3 Surgical Instrument Handling, Tray Setup & Sterilization

12 Chapter 11: Patient Services, Education & Clinical Care

11.1 Patient Education, Chronic Disease Counseling & Treatment Adherence 11.2 Special Needs Accommodations, Patient Diversity & Interpersonal Skills 11.3 Ophthalmic Emergencies, First Aid & Clinical Care Coordination 11.4 Clinic Operations, Research Support, Forms & Referrals

13 Chapter 12: General Ocular Anatomy & Retinal Physiology

12.1 Ocular Anatomy, Orbit & Posterior Segment Architecture 12.2 Ten Retinal Layers, Photoreceptors & Macular Anatomy 12.3 Ocular Blood Supply, Microcirculation & Vitreoretinal Interface 12.4 Body Systems, Ocular Adnexa & Medical Terminology

14 Chapter 13: Retinal Pathology & Systemic Disease Manifestations

13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions 13.2 Diabetic Retinopathy & Systemic Diseases Affecting the Retina 13.3 Peripheral Retinal Degenerations, Tears & Detachments

15 Chapter 14: Ophthalmic Optics & Lensometry

14.1 Principles of Ophthalmic Optics & Refraction 14.2 Manual & Automated Lensometry Techniques

16 Chapter 15: Fundus Photography & Ophthalmic Angiography

15.1 Fundus Photography Techniques & Fundus Autofluorescence 15.2 Fluorescein Angiography Principles, Phases & Image Interpretation 15.3 Indocyanine Green Angiography & Angiographic Complication Management

17 Chapter 16: Optical Coherence Tomography (OCT & OCT-A)

16.1 OCT Principles, Scan Acquisition & Artifact Recognition 16.2 Structural OCT Interpretation: Retinal Fluid & Biomarkers 16.3 Optical Coherence Tomography Angiography (OCT-A) Principles & Flow

18 Chapter 17: Equipment Maintenance, Ethics & Regulatory Compliance

17.1 Equipment Maintenance, Calibration Schedules & Clinic Safety 17.2 Medical Ethics, Scope of Practice & Informed Consent 17.3 Patient Privacy, HIPAA Standards & Hazardous Waste Disposal

2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP

Key Takeaways Explain This Topic AI

Use the chart at an approved shorter distance before switching to qualitative notations when the chart and room configuration allow it.

Counting-fingers results require a measured distance and reproducible responses; hand-motion testing records whether movement is detected under specified conditions.

Light perception and light localization are separate observations, and the chart should record the light source, lighting, tested eye, and reliability limitations.

No-light-perception is a measured response under controlled conditions, not a declaration that blindness is irreversible or that no treatment question remains.

Prevent fellow-eye peeking and stray-light cues, but follow clinic policy rather than an invented universal rule requiring two examiners or one particular device.

Last updated: September 2026

Sub-Chart Acuity: CF, HM, LP, and NLP

Visual acuity is most comparable when measured with calibrated optotypes. If the patient cannot identify the largest symbol at the standard distance, first follow the chart's instructions for moving closer or using a low-vision chart. Only then move to qualitative or semiquantitative responses. The goal is to document what the patient actually demonstrates, not to force every patient through a rigid ritual.

Prepare the test

Confirm the eye, habitual distance correction, testing distance, chart illumination, and whether a pinhole or trial lens is being used. Test monocularly unless binocular function is the stated task. Use an opaque occluder that does not press on a recently operated eye, and watch for peeking around its edge. Explain the task in language and a format the patient can understand.

Poor responses can reflect hearing, language, cognition, fatigue, photophobia, poor fixation, or an inaccessible test—not only ocular disease. Record these limitations.

Counting fingers

Present a small, changing number of fingers against a plain, contrasting background at a measured distance. Avoid giving rhythm, voice, reflection, or shadow cues. Repeat enough trials to establish that responses are reproducible. If the patient succeeds, record the tested eye and distance, for example CF at 1 m or CF at 2 ft , according to local notation.

The exact finger choices and starting distance are protocol-dependent. What matters is a consistent method, measured distance, adequate lighting, complete fellow-eye occlusion, and reproducible identification. A bare entry of CF omits important information.

Hand motion

If fingers cannot be counted at the closest approved distance, test whether the patient can detect a moving hand under controlled illumination. Keep the test position and distance consistent and vary movement with nonmovement so the patient cannot answer from timing alone. Some clinics ask the patient to identify direction; others document detection of motion. Use the clinic's defined method and record the conditions.

Hand motion is not a precise Snellen equivalent. Do not convert HM into an invented chart fraction or compare it as though it were a linear acuity value.

Light perception and localization

If hand motion is not reproducibly detected, test whether the patient can distinguish the light source on from off. Reduce ambient light enough to control stray cues and use the clinic-approved light source. Shield the fellow eye and change the timing of presentations. A reliable on/off response is documented as LP .

Light localization or projection asks where the light originates, often from several directions. It may add information, but it is not the same as visual acuity and should be recorded separately. Do not tell a patient that one localization result determines surgical prognosis.

No light perception

Record NLP only after repeated controlled presentations produce no reliable light detection. Recheck eye identity, pupil exposure, battery and light output, occlusion, understanding, and response reliability. Follow facility policy for confirmation, especially when the result is new, unexpected, inconsistent with pupillary findings, or has major management implications.

NLP describes the response during that examination. It does not by itself establish cause, duration, permanence, legal blindness status, or whether urgent treatment is indicated. The licensed clinician integrates the result with pupils, anatomy, imaging, and history.

Documentation table

  • Response What is tested Essential documentation
  • Short-distance chart Optotype recognition Chart, distance, correction, letters or line
  • CF Number of fingers Eye, measured distance, lighting, reliability
  • HM Motion detection or direction Eye, distance, method, reliability
  • LP Light on versus off Eye, source, ambient conditions, reliability
  • Light localization Direction of source Directions tested and responses
  • NLP No reproducible light detection Controlled conditions, recheck, limitations

Use neutral wording. If responses vary, document the range and reason rather than selecting the best trial without explanation.

Documentation and repeatability controls

Record the exact chart or stimulus, test distance, correction, lighting, eye, occlusion method, and patient response. For counting fingers, document the distance and field used; for hand motion, document the distance and direction when the protocol requires it. For light perception, identify whether projection was tested and how. A bare entry such as "CF" cannot be compared reliably with a later "CF at 1 foot."

Before accepting a major decline, check identity, laterality, habitual correction, occlusion, room setup, and comprehension. Reposition the patient and repeat only enough to confirm a reproducible response without coaching. If the response changes, document both the initial and repeat result and what changed. Escalate a new or unexplained reduction promptly. Do not infer irreversible blindness from NLP, and do not promise prognosis from any sub-chart category; media opacity, severe retinal disease, optic-nerve disease, neurologic factors, and testing conditions all require clinician assessment.